Novartis receives CHMP positive opinion for Enerzair® Breezehaler® (QVM149), a potential first-in-class inhaled LABA/LAMA/ICS combination for uncontrolled asthma May 1, 2020
‘The world will never be the same’: Healthcare executives say telehealth is here to stay beyond the coronavirus May 1, 2020
